Mutations in GBA and risk of Parkinson’s disease: a meta-analysis based on 25 case-control studies

References

• de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525–35.
   PubMed Web of Science ®Google Scholar
• Schulte C, Gasser T. Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl Clin Genet. 2011;4:67–80.
   PubMedGoogle Scholar
• Bembi B, Marsala SZ, Sidransky E, Ciana G, Carrozzi M, Zorzon M, et al.. Gaucher's disease with Parkinson's disease: clinical and pathological aspects. Neurology. 2003;61:99–101.
   PubMed Web of Science ®Google Scholar
• Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab. 2004;81:70–3.
   PubMed Web of Science ®Google Scholar
• Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet. 1989;2:349–52.
   PubMed Web of Science ®Google Scholar
• Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29:567–83.
   PubMed Web of Science ®Google Scholar
• Sato C, Morgan A, Lang AE, Salehi-Rad S, Kawarai T, Meng Y, et al.. Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov Disord. 2005;20:367–70.
   PubMed Web of Science ®Google Scholar
• Mao XY, Burgunder JM, Zhang ZJ, An XK, Zhang JH, Yang Y, et al.. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China. Neurosci Lett. 2010;469:256–9.
   PubMed Web of Science ®Google Scholar
• Spitz M, Rozenberg R, Pereira Lda V, Reis Barbosa E. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil. Parkinsonism Relat Disord. 2008;14:58–62.
   PubMed Web of Science ®Google Scholar
• Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T, et al.. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology. 2008;70:2277–83.
   PubMed Web of Science ®Google Scholar
• Emelyanov A, Boukina T, Yakimovskii A, Usenko T, Drosdova A, Zakharchuk A, et al.. Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia. Mov Disord. 2012;27:158–9.
   PubMed Web of Science ®Google Scholar
• Nishioka K, Vilarino-Guell C, Cobb SA, Cobb SA, Kachergus JM, Mann DM, et al.. Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa. Neurosci Lett. 2010;477:57–60.
   PubMed Web of Science ®Google Scholar
• Toft M, Pielsticker L, Ross OA, Aasly JO, Farrer MJ. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population. Neurology. 2006;66:415–7.
   PubMed Web of Science ®Google Scholar
• Eblan MJ, Nguyen J, Ziegler SG, Lwin A, Hanson M, Gallardo M, et al.. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov Disord. 2006;21:282–3.
   PubMed Web of Science ®Google Scholar
• Kumar KR, Ramirez A, Gobel A, Kresojević N, Svetel M, Lohmann K, et al.. Glucocerebrosidase mutations in a Serbian Parkinson's disease population. Eur J Neurol. 2012; 1468–331.
   Google Scholar
• Choi JM, Kim WC, Lyoo CH, Kang SY, Lee PH, Baik JS, et al.. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population. Neurosci Lett. 2012;514:12–5.
   PubMed Web of Science ®Google Scholar
• Lesage S, Condroyer C, Hecham N, Anheim M, Belarbi S, Lohman E, et al.. Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa. Neurology. 2011;76:301–3.
   PubMed Web of Science ®Google Scholar
• Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2004;351:1972–7.
   PubMed Web of Science ®Google Scholar
• Hu FY, Xi J, Guo J, Yu LH, Liu L, He XH, et al.. Association of the glucocerebrosidase N370S allele with Parkinson's disease in two separate Chinese Han populations of mainland China. Eur J Neurol. 2010;17:1476–8.
   PubMed Web of Science ®Google Scholar
• Huang CL, Wu-Chou YH, Lai SC, Chang HC, Yeh TH, Weng YH, et al.. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan. Eur J Neurol. 2011;18:1227–32.
   PubMed Web of Science ®Google Scholar
• Sun QY, Guo JF, Wang L, Yu RH, Zuo X, Yao LY, et al.. Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson's disease in Chinese population. Mov Disord. 2010;25:1005–11.
   PubMed Web of Science ®Google Scholar
• Ziegler SG, Eblan MJ, Gutti U, Hruska KS, Stubblefield BK, Goker-Alpan O, et al.. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab. 2007;91:195–200.
   PubMed Web of Science ®Google Scholar
• Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al.. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009;361:1651–61.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
   PubMedGoogle Scholar
• Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7:889–894.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Socal MP, Bock H, Michelin-Tirelli K, Hilbig A, Saraiva-Pereira ML, Rieder CR, et al.. Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians. Parkinsonism Relat Disord. 2009;15:76–8.
   PubMed Web of Science ®Google Scholar
• Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, et al.. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology. 2009;72:310–6.
   PubMed Web of Science ®Google Scholar
• Wu YR, Chen CM, Chao CY, Ro LS, Lyu RK, Chang KH, et al.. Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. J Neurol Neurosurg Psychiatry. 2007;78:977–9.
   PubMed Web of Science ®Google Scholar
• Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, et al.. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord. 2005;20:100–3.
   PubMed Web of Science ®Google Scholar
• Bras J, Paisan-Ruiz C, Guerreiro R, Ribeiro MH, Morgadinho A, Januario C, et al.. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol Aging. 2009;30:1515–7.
   PubMed Web of Science ®Google Scholar
• De Marco EV, Annesi G, Tarantino P, Rocca FE, Provenzano G, Civitelli D, et al.. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. Mov Disord. 2008;23:460–3.
   PubMed Web of Science ®Google Scholar
• Seto-Salvia N, Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, et al.. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov Disord. 2012;27:393–9.
   PubMed Web of Science ®Google Scholar
• Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, et al.. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 2009;132:1783–94.
   PubMed Web of Science ®Google Scholar
• Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, et al.. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet. 2011;20:202–10.
   PubMed Web of Science ®Google Scholar
• Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J, et al.. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol. 2009;66:571–6.
   PubMed Web of Science ®Google Scholar
• Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, et al.. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 2007;69:1270–7.
   PubMed Web of Science ®Google Scholar
• Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett. 2009;452:87–9.
   PubMed Web of Science ®Google Scholar
• Tan E-K, Tong J, Fook-Chong S, Yih Y, Wong MC, Pavanni R, et al.. Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol. 2007;64:1056–8.
   PubMed Web of Science ®Google Scholar
• Moraitou M, Hadjigeorgiou G, Monopolis I, Dardiotis E, Bozi M, Vassilatis D, et al.. beta-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease. Mol Genet Metab. 2011;104:149–52.
   PubMed Web of Science ®Google Scholar
• de Carvalho Guimarães B, Valente Pereira AC, da Costa Rodrigues F, dos Santos AV, Campos M, dos Santos JM, et al.. Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson’s disease in Brazilian patients. Parkinsonism Relat Disord. 2012;18:688–9.
   PubMed Web of Science ®Google Scholar
• Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989;4 (1):87–96.
   PubMed Web of Science ®Google Scholar
• Tsuji S, Choudary PV, Martin BM. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med. 1987;316:570–5.
   PubMed Web of Science ®Google Scholar
• Tsuji S, Martin BM, Barranger JA, Stubblefield BK, LaMarca ME, Ginns EI. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci U S A. 1988;85:2349–52.
   PubMed Web of Science ®Google Scholar
• Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, et al.. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36:388–93.
   PubMed Web of Science ®Google Scholar